US President Donald Trump has announced plans to impose 100% tariffs on imported generic medicines from August 2028, rising to 200% after one year, in a move analysts say could disrupt India's…
India’s pharmaceutical exports grew 6.8% year-on-year to $8.1 billion in the first quarter ended June, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) said. Drug formulations and biologicals, the largest category, rose…
Glenmark Pharmaceuticals' US subsidiary has agreed to pay $15.28 million to settle antitrust litigation with Humana Inc, the company said in a stock exchange filing on Tuesday. The case involved allegations of…
India's pharmaceutical exports rose 6.8% to $8.1 billion in the April-June quarter of FY27, driven by strong overseas demand for vaccines and bulk drugs, the Pharmaceuticals Export Promotion Council of India (Pharmexcil)…
Indian pharmaceutical companies are not rushing to move manufacturing to the United States despite former President Donald Trump's threat of up to 200 percent tariffs on imported generic drugs after a two-year…
Shares of Gland Pharma rose over 4% on Tuesday after the Hyderabad-based drugmaker received US FDA approval for its generic version of Sugammadex injection, used to reverse the effects of certain muscle…
Alembic Pharmaceuticals has received final USFDA approval for its generic Prucalopride Tablets, used to treat chronic idiopathic constipation in adults. The drug is therapeutically equivalent to Takeda's Motegrity. Based on IQVIA data,…
